No: It is a peripheral α-adrenergic agonist, finds use in the clinical management of patients with orthostatic hypotension or hypotension secondary to other clinical conditions or drug therapies. In patients with refractory orthostatic hypotension oral midodrine increases standing blood pressure and improves symptoms of orthostatism, such as weakness, syncope, blurred vision and fatigue.
Answered 11/5/2013
4.8k views
Midodrine: Midodrine is an Alpha agonist but has relatively little data compared to most other approved drugs. It shouldn't reduce pulmonary blood flow but i can't find data to prove that.
Answered 9/28/2016
4.8k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question